의약품 수탁 포장 시장 규모, 점유율, 분석 리포트 : 유형별, 재료별, 지역별, 부문별 예측(2025-2030년)

Pharmaceutical Contract Packaging Market Growth & Trends:

The global pharmaceutical contract packaging market size is expected to reach USD 26.2 billion by 2030, registering a CAGR of 7.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Access to advanced technologies, cost-saving, and focus on core competencies are anticipated to propel market growth.

The growing pharmaceutical industry with high competition within the market is the major factor driving the market. Pharmaceutical companies are outsourcing packaging activities to third parties, mainly in emerging nations such as China, India, and Brazil. Further, rising pricing pressure on pharmaceutical companies is boosting the demand for contract packaging services in the industry. The stringent regulatory scenario in developed countries and changing regulations in emerging countries are driving the market.

Moreover, large Contract Packaging Organizations (CPOs) and Contract Development and Manufacturing Organizations (CDMOs) are continually acquiring small contract service providers to fill any gaps in the value chain or expand their existing portfolios. As smaller service providers have customer bases that comprise small and mid-sized pharmaceutical companies, it allows larger CPOs and CDMOs to better compete with small service providers. Thus, maintaining the threat of new entrants at a moderate level for larger CPOs and CDMOs.

In addition, lack of in-house wrapping capabilities, expertise, and budget constraints are the major issues faced by small pharmaceutical companies in the industry. Contract packaging service providers are recognized as a practical approach to curbing such problems of small companies owing to the low-cost service offering. The lack of resources and budgets has prompted many small pharmaceutical companies to establish mutually beneficial relationships with CPOs and CDMOs. Contract service providers are making significant attempts to meet their client's expectations and provide highly sophisticated wrapping facilities.

The stringent regulations in developed regions such as North America and Europe are expected to drive the market over the forecast period. For instance, compulsory barcodes system for pharmaceutical wrapping and the transfer of large volumes of data related to the supply of medicines under serialization legislation.

Pharmaceutical Contract Packaging Market Report Highlights:

• By type, primary packaging led segment dominating the market with the largest revenue share of 76.6% in 2024 due to the essential role primary packaging plays in safeguarding the pharmaceutical product's integrity, safety, and compliance.
• The secondary packaging segment is expected to grow significantly over the forecast period, driven by the increasing need for enhanced branding, consumer safety, and regulatory compliance.
• The plastics and polymers segment contributed the largest revenue share, 41.5%, by 2024, mainly due to their versatility, cost-effectiveness, durability, ease of manufacturing, and ability to be molded into various shapes and sizes.
• North America's pharmaceutical contract packaging market has dominated the global market and accounted for the largest revenue share of 36.0% in 2024 due to the region's highly established pharmaceutical industry, technological advancements, and regulations.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Pharmaceutical Contract Packaging Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Billion)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Pharmaceutical Contract Packaging Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Pharmaceutical Contract Packaging Market: Type Estimates & Trend Analysis

• 4.1. Type Market Share, 2024 & 2030
• 4.2. Type Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Billion)
• 4.4. Primary Packaging
  • 4.4.1. Primary Packaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4.2. Bottles
    • 4.4.2.1. Bottles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4.3. Vials
    • 4.4.3.1. Vials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4.4. Ampoules
    • 4.4.4.1. Ampoules Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4.5. Blister Packs
    • 4.4.5.1. Blister Packs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4.6. Others
    • 4.4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.5. Secondary Packaging
  • 4.5.1. Secondary Packaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.6. Tertiary Packaging
  • 4.6.1. Tertiary Packaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Pharmaceutical Contract Packaging Market: Material Estimates & Trend Analysis

• 5.1. Material Market Share, 2024 & 2030
• 5.2. Material Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Material, 2018 to 2030 (USD Billion)
• 5.4. Plastics & Polymers
  • 5.4.1. Plastics & Polymers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.5. Paper & Paperboard
  • 5.5.1. Paper & Paperboard Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.6. Glass
  • 5.6.1. Glass Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.7. Aluminum Foil
  • 5.7.1. Aluminum Foil Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.8. Others
  • 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Pharmaceutical Contract Packaging Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. North America Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework
    • 6.4.2.3. Competitive Insights
    • 6.4.2.4. U.S. Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework
    • 6.4.3.3. Competitive Insights
    • 6.4.3.4. Canada Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Regulatory Framework
    • 6.4.4.3. Competitive Insights
    • 6.4.4.4. Mexico Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.5. Europe
  • 6.5.1. Europe Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework
    • 6.5.2.3. Competitive Insights
    • 6.5.2.4. UK Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework
    • 6.5.3.3. Competitive Insights
    • 6.5.3.4. Germany Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework
    • 6.5.4.3. Competitive Insights
    • 6.5.4.4. France Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework
    • 6.5.5.3. Competitive Insights
    • 6.5.5.4. Italy Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework
    • 6.5.6.3. Competitive Insights
    • 6.5.6.4. Spain Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.7. Sweden
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Regulatory Framework
    • 6.5.7.3. Competitive Insights
    • 6.5.7.4. Sweden Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.8. Denmark
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Regulatory Framework
    • 6.5.8.3. Competitive Insights
    • 6.5.8.4. Denmark Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.9. Norway
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Regulatory Framework
    • 6.5.9.3. Competitive Insights
    • 6.5.9.4. Norway Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework
    • 6.6.2.3. Competitive Insights
    • 6.6.2.4. Japan Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework
    • 6.6.3.3. Competitive Insights
    • 6.6.3.4. China Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework
    • 6.6.4.3. Competitive Insights
    • 6.6.4.4. India Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6.5. Thailand
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework
    • 6.6.5.3. Competitive Insights
    • 6.6.5.4. Thailand Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6.6. South Korea
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework
    • 6.6.6.3. Competitive Insights
    • 6.6.6.4. South Korea Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6.7. Australia
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Framework
    • 6.6.7.3. Competitive Insights
    • 6.6.7.4. Australia Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.7. Latin America
  • 6.7.1. Latin America Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework
    • 6.7.2.3. Competitive Insights
    • 6.7.2.4. Brazil Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework
    • 6.7.3.3. Competitive Insights
    • 6.7.3.4. Argentina Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.8. Middle East and Africa
  • 6.8.1. Middle East and Africa Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework
    • 6.8.2.3. Competitive Insights
    • 6.8.2.4. South Africa Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework
    • 6.8.3.3. Competitive Insights
    • 6.8.3.4. Saudi Arabia Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework
    • 6.8.4.3. Competitive Insights
    • 6.8.4.4. UAE Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Amcor plc
    • 7.5.1.1. Participant's Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Recent Developments/ Strategic Initiatives
  • 7.5.2. BALL CORPORATION
    • 7.5.2.1. Participant's Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Recent Developments/ Strategic Initiatives
  • 7.5.3. Nipro Corporation
    • 7.5.3.1. Participant's Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Recent Developments/ Strategic Initiatives
  • 7.5.4. Daito Pharmaceutical Co. Ltd
    • 7.5.4.1. Participant's Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Recent Developments/ Strategic Initiatives
  • 7.5.5. Pfizer CentreOne
    • 7.5.5.1. Participant's Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Recent Developments/ Strategic Initiatives
  • 7.5.6. CELESTICA INC.
    • 7.5.6.1. Participant's Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Recent Developments/ Strategic Initiatives
  • 7.5.7. West Pharmaceutical Services, Inc.
    • 7.5.7.1. Participant's Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Recent Developments/ Strategic Initiatives
  • 7.5.8. WestRock Company
    • 7.5.8.1. Participant's Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Recent Developments/ Strategic Initiatives
  • 7.5.9. Patheon
    • 7.5.9.1. Participant's Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Recent Developments/ Strategic Initiatives
  • 7.5.10. Baxter BioPharma Solutions
    • 7.5.10.1. Participant's Overview
    • 7.5.10.2. Financial Performance
    • 7.5.10.3. Product Benchmarking
    • 7.5.10.4. Recent Developments/ Strategic Initiatives